The role of Topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracyclines based chemotherapy in locally advanced breast cancer

被引：0

作者：

Gamea, M. ^{[1
]}

机构：

[1] Aswan Univ, Clin Oncol, Tanta, Egypt

来源：

EUROPEAN JOURNAL OF CANCER | 2018年 / 92卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

389 (PB-02

引用

页码：S111 / S111

页数：1

共 50 条

[1] The role of topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracyclines based chemotherapy in locally advanced breast cancer
Gamea, M.
EUROPEAN JOURNAL OF CANCER, 2017, 72 : S37 - S37
[2] The role of Topoisomerase II-α (TOPO IIA) as a predictive factor of response neoadjuvant anthracyclines based chemotherapy in locally advanced breast cancer
Gamea, M.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 140 - 141
[3] The role of Topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracyclines based chemotherapy in locally advanced breast cancer
Gamea, M. M.
EUROPEAN JOURNAL OF CANCER, 2018, 92 : S12 - S13
[4] THE ROLE OF TOPOISOMERASE II-A (TOPO IIA) AS A PREDICTIVE FACTOR FOR RESPONSE TO NEOADJUVANT ANTHRACYCLINES BASED CHEMOTHERAPY IN LOCALLY ADVANCED BREAST CANCER
Gamea, M.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 614 - 614
[5] The role of topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracycline-based chemotherapy in locally advanced breast cancer
Gamea, M. M.
ANNALS OF ONCOLOGY, 2018, 29 : 28 - 28
[6] The role of topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracycline-based chemotherapy in locally advanced breast cancer
Gamea, M.
ANNALS OF ONCOLOGY, 2018, 29 : 33 - 33
[7] THE ROLE OF TOPOISOMERASE [IIA] AS A PREDICTIVE FACTOR FOR RESPONSE TO NEOADJUVANT ANTHRACYCLINES BASED CHEMOTHERAPY IN LOCALLY ADVANCED BREAST CANCER
Gamea, Mohamed
Asia-Pacific Journal of Clinical Oncology, 2015, 11 : 123 - 123
[8] Topoisomerase II-α as a predictive factor of response to therapy with anthracyclines in locally advanced breast cancer
Gomez, Henry L.
Pinto, Joseph A.
Olivera, Mivael
Vidaurre, Tatiana
Doimi, Franco D.
Vigil, Carlos E.
Velarde, Raul G.
Abugattas, Julio E.
Alarcon, Edith
Vallejos, Carlos S.
BREAST, 2011, 20 (01): : 39 - 45
[9] Topoisomerase II-α amplification as potential predictive marker of complete response to anthracycline-based chemotherapy in locally advanced/metastatic breast cancer.
Cardoso, F
Durbecq, V
Bernard-Marty, C
Rouas, G
Leroy, JY
Max, M
Giuliani, R
Larsimont, D
Jacobson, K
Piccart, MJ
Di Leo, A
BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S64 - S64
[10] Neo-adjuvant anthracycline based chemotherapy in locally advanced breast cancer: assessment of topoisomerase IIA with response
Singer, J.
Dewdney, A.
Mapp, L.
Bradpiece, H. A.
Jenkins, S.
Jader, S.
Patel, A.
EJC SUPPLEMENTS, 2009, 7 (02): : 311 - 311

← 1 2 3 4 5 →